During the past decade, HIMA San Pablo Oncologic Hospital conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 5 clinical trials were completed, i.e. on average, 12.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 5 clinical trials were completed. i.e. 31.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HIMA San Pablo Oncologic Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "Children's Oncology Group" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "Alliance for Clinical Trials in Oncology" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HIMA San Pablo Oncologic Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "HIMA San Pablo Oncologic Hospital" are "B Acute Lymphoblastic Leukemia" (3 trials), "Acute Promyelocytic Leukemia With PML-RARA" (2 trials), "Alveolar Rhabdomyosarcoma" (2 trials), "Anaplastic Astrocytoma" (2 trials) and "Botryoid-Type Embryonal Rhabdomyosarcoma" (2 trials). Many other conditions were trialed in "HIMA San Pablo Oncologic Hospital" in a lesser frequency.

Most popular intervention types in "HIMA San Pablo Oncologic Hospital" are "Drug" (34 trials), "Other" (27 trials), "Procedure" (23 trials), "Biological" (18 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (13 trials), "Biospecimen Collection" (12 trials), "Cyclophosphamide" (12 trials), "Quality-of-Life Assessment" (12 trials) and "Vincristine Sulfate" (12 trials). Other intervention names were less common.

The vast majority of trials in "HIMA San Pablo Oncologic Hospital" are 35 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "HIMA San Pablo Oncologic Hospital". undefined are not yet recruiting, 21 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in HIMA San Pablo Oncologic Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in HIMA San Pablo Oncologic Hospital, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".